Hudson Bay Capital Management »

Vir Biotechnology shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $6.2M 850k 7.34
2024-09-30 $4.0M 528k 7.49
2024-06-30 $3.8M 425k 8.90
2024-03-31 $2.9M 285k 10.13
2023-12-31 $2.9M 290k 10.06
2023-09-30 $1.9M 208k 9.37
2023-06-30 $245k 10k 24.53

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation Call Option (MSFT)
Advanced Micro Devices Put Option (AMD)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Eli Lilly & Co. Call Option (LLY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
UnitedHealth Put Option (UNH)
Taiwan Semiconductor Mfg Sponsored Ads Put Option (TSM)
Microstrategy Cl A New Call Option (MSTR)
Dollar Tree Put Option (DLTR)

View all positions for Hudson Bay Capital Management

Top funds holding Vir Biotechnology

Sb Investment Advisers
BlackRock
Vanguard Group
State Street Corporation
OrbiMed Advisors
Geode Capital Management
Dimensional Fund Advisors
Jpmorgan Chase & Co
Millennium Management
Ikarian Capital
Bill & Melinda Gates Foundation
Charles Schwab Investment Management
Renaissance Technologies
Morgan Stanley
Baker Bros. Advisors

View all funds holding Vir Biotechnology